PDCD1 and myeloid sarcoma: In people with MS, the PD-1 gene polymorphism (PD-1.3), which is related to reduced PD-1 activity, was associated with a progressive course of the disease, possibly due to a partial defect in PD-1–mediated inhibition of T-cell activation (86).